Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SLE and antiphospholipid syndrome [240–264]

Identifieur interne : 001F56 ( Main/Exploration ); précédent : 001F55; suivant : 001F57

SLE and antiphospholipid syndrome [240–264]

Auteurs :

Source :

RBID : ISTEX:CD8E7F0B58A269299F02CBF9D74AA201C547C685

English descriptors


Url:
DOI: 10.1093/oxfordjournals.rheumatology.a005773


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SLE and antiphospholipid syndrome [240–264]</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CD8E7F0B58A269299F02CBF9D74AA201C547C685</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1093/oxfordjournals.rheumatology.a005773</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-82LNLBNL-Q/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002705</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002705</idno>
<idno type="wicri:Area/Istex/Curation">002705</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D97</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D97</idno>
<idno type="wicri:Area/Main/Merge">001F71</idno>
<idno type="wicri:Area/Main/Curation">001F56</idno>
<idno type="wicri:Area/Main/Exploration">001F56</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">SLE and antiphospholipid syndrome [240–264]</title>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Rheumatology</title>
<title level="j" type="issue">British Society for Rheumatology Annual Meeting 20–23 April 2004 Edinburgh, Scotland and British Health Professionals Spring Meeting 21–23 April 2004 Edinburgh, Scotland</title>
<title level="j" type="abbrev">Rheumatology</title>
<idno type="ISSN">1462-0324</idno>
<idno type="eISSN">1462-0332</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date when="2004-04">2004</date>
<biblScope unit="vol">43</biblScope>
<biblScope unit="issue">suppl_2</biblScope>
<biblScope unit="page" from="ii103">ii103</biblScope>
<biblScope unit="page" to="ii110">ii110</biblScope>
</imprint>
<idno type="ISSN">1462-0324</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1462-0324</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Abdominal angina</term>
<term>Abnormal</term>
<term>Abnormal abis</term>
<term>Abnormal abpi</term>
<term>Abpi</term>
<term>Academic department</term>
<term>Academic unit</term>
<term>Adverse events</term>
<term>American college</term>
<term>Antibody</term>
<term>Anticardiolipin antibodies</term>
<term>Antiphospholipid</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Antiphospholipid syndrome thursday</term>
<term>Antithyroid antibodies</term>
<term>April</term>
<term>Arginine</term>
<term>Arginine residues</term>
<term>Autoimmune phenotype</term>
<term>Autoimmunity</term>
<term>Baseline</term>
<term>Biology unit</term>
<term>Blood pressure</term>
<term>Blood tests</term>
<term>Bxsb strain</term>
<term>Cardiac</term>
<term>Cardiac lupus</term>
<term>Cardiovascular</term>
<term>Cardiovascular disease</term>
<term>Cardiovascular risk</term>
<term>Cardiovascular risk factors</term>
<term>Carotid arteries</term>
<term>Caucasian</term>
<term>Cell supernatants</term>
<term>Centre</term>
<term>Chain combinations</term>
<term>Chase farm hospital</term>
<term>Chest infection</term>
<term>Chest pain</term>
<term>Child health</term>
<term>Chromosome</term>
<term>Chronic headache</term>
<term>Clinical evidence</term>
<term>Clinical immunology</term>
<term>Clinical utility</term>
<term>Coeliac</term>
<term>Coeliac artery stenosis</term>
<term>Cohort</term>
<term>Common problem</term>
<term>Complementary therapies</term>
<term>Complete occlusion</term>
<term>Confocal microscopy</term>
<term>Congenic mice</term>
<term>Congenic strain</term>
<term>Connective tissue disease</term>
<term>Consecutive patients</term>
<term>Consensus statement</term>
<term>Control group</term>
<term>Control subjects</term>
<term>Daily questionnaire</term>
<term>Diabetes mellitus</term>
<term>Disease activity</term>
<term>Disease duration</term>
<term>Disease susceptibility</term>
<term>Dsdna</term>
<term>Elisa</term>
<term>Environmental quality</term>
<term>Eric bywaters centre</term>
<term>Erythematosus</term>
<term>Ethnic origin</term>
<term>Family history</term>
<term>Fasting</term>
<term>Fasting insulin levels</term>
<term>Fasting lipids</term>
<term>Haplotype</term>
<term>Hazard ratio</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Healthy controls subjects</term>
<term>Healthy subjects</term>
<term>High prevalence</term>
<term>High sensitivity</term>
<term>Higher frequency</term>
<term>Hormone replacement therapy</term>
<term>Hughes syndrome</term>
<term>Human antibody</term>
<term>Hyper responsiveness</term>
<term>Hypertension</term>
<term>Hypertensive</term>
<term>Immunology</term>
<term>Immunology department</term>
<term>Imperial college</term>
<term>Important role</term>
<term>India institute</term>
<term>Intima media thickness</term>
<term>Ischaemic heart disease</term>
<term>Italy background</term>
<term>Khamashta</term>
<term>Kingdom background</term>
<term>Laboratory data</term>
<term>Laboratory factors</term>
<term>Leeds</term>
<term>Light chains</term>
<term>Lipid</term>
<term>Lipid rafts</term>
<term>Livedo</term>
<term>Livedo reticularis</term>
<term>Lmwh</term>
<term>Lmwh treatment</term>
<term>Locus</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lupus patients</term>
<term>Lupus research unit</term>
<term>Magnetic resonance angiography</term>
<term>Median</term>
<term>Median disease duration</term>
<term>Medical records</term>
<term>Medical sciences</term>
<term>Molecular weight heparin</term>
<term>Monoclonal antibodies</term>
<term>Morbidity</term>
<term>Musculoskeletal disease</term>
<term>Mutation</term>
<term>Normal range</term>
<term>Northwick park hospital</term>
<term>Oral prednisolone treatment</term>
<term>Pap</term>
<term>Paps group</term>
<term>Paps patients</term>
<term>Pilot study</term>
<term>Polyarteritis nodosa</term>
<term>Positive patients</term>
<term>Possible associations</term>
<term>Poster session</term>
<term>Prednisolone</term>
<term>Prednisolone treatment</term>
<term>Pregnancy morbidity</term>
<term>Prevalence</term>
<term>Primary antiphospholipid syndrome</term>
<term>Primary antiphospholipid syndrome baron</term>
<term>Primary syndrome</term>
<term>Prospective study</term>
<term>Psychological quality</term>
<term>Randomised trial</term>
<term>Range years</term>
<term>Rayne</term>
<term>Rayne institute</term>
<term>Renal</term>
<term>Renal artery stenosis</term>
<term>Renal disease</term>
<term>Renal impairment</term>
<term>Renal involvement</term>
<term>Reticularis</term>
<term>Rheumatic diseases</term>
<term>Rheumatology</term>
<term>Rheumatology section</term>
<term>Risk factors</term>
<term>Sapporo criteria</term>
<term>Serine mutation</term>
<term>Single mutation</term>
<term>Spontaneous autoimmunity</term>
<term>Spontaneous proliferation</term>
<term>Stable expression system</term>
<term>Stenosis</term>
<term>Steroid</term>
<term>Strict protocol</term>
<term>Syndrome</term>
<term>Systemic</term>
<term>Systemic lupus erythematosus</term>
<term>Systemic vasculitides</term>
<term>Tertiary referral centre</term>
<term>Thrombosis</term>
<term>Thrombotic microangiopathy</term>
<term>Total cholesterol</term>
<term>Transient expression system</term>
<term>Treatment period</term>
<term>Troublesome symptoms</term>
<term>University college london</term>
<term>Vasculitis</term>
<term>Wide variety</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F56 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F56 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:CD8E7F0B58A269299F02CBF9D74AA201C547C685
   |texte=   SLE and antiphospholipid syndrome [240–264]
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021